The test combines qPCR and microarray technology to detect carbapenemase-producing enterobacteriaceae, a bacteria resistance to carbapenem antibiotics.
At least two early-access users, at Massachusetts General Hospital and at Weill Cornell, have explored the new platform for infectious disease testing.
ARMADA began as a consortium of eight US organizations but has increased to 50 institutions in 20 countries and signed on actor Bill Pullman as a spokesman.
The scientists collected fecal samples from more than 9,000 pigs and chickens to find in excess of 400 antimicrobial resistance genes, which varied by country.
In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.
